Redx Pharma

Redx Pharma is a drug discovery and development company formed in September 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in two main areas, cancer and infectious disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.
Redx Pharma has two subsidiaries: Redx Oncology Ltd launched in April 2012 and Redx Anti-Infectives Ltd launched in April 2013.

Company Growth (employees)
Liverpool, GB
Size (employees)
145 (est)
Redx Pharma was founded in 2010 and is headquartered in Liverpool, GB

Redx Pharma Office Locations

Redx Pharma has offices in Liverpool and Cheshire East
Liverpool, GB (HQ)
Daulby St
Cheshire East, GB
Alderley Park

Redx Pharma Data and Metrics

Redx Pharma Financial Metrics

Redx Pharma's revenue was reported to be £1.3 m in FY, 2013

Net income (FY, 2016)

(15.5 m)

Market capitalization (24-May-2017)

30.3 m

Closing share price (24-May-2017)


Cash (30-Sep-2016)

5.8 m
Redx Pharma's current market capitalization is £30.3 m.
GBPFY, 2013FY, 2014FY, 2015FY, 2016


1.3 m

Pre tax profit

(4.3 m)(8.8 m)(15.4 m)

Net Income

(3.4 m)(8.2 m)(15.5 m)
GBPFY, 2014FY, 2015FY, 2016


2.9 m9.4 m5.8 m

Accounts Receivable

114 k452 k469 k

Current Assets

6.6 m12.3 m7.9 m


130 k1.1 m1.1 m
GBPFY, 2014FY, 2015FY, 2016

Cash From Operating Activities

(2.2 m)(6.5 m)(12.5 m)

Cash From Financing Activities

4.1 m13.4 m9.3 m

Income Taxes Paid

910 k650 k(114 k)
Y, 2016

Financial Leverage

5.5 x
Show all financial metrics

Redx Pharma Market Value History

Traffic Overview of Redx Pharma

Redx Pharma Online and Social Media Presence

Redx Pharma Company Life and Culture

You may also be interested in